Anzeige
Mehr »
Donnerstag, 11.12.2025 - Börsentäglich über 12.000 News
News von heute Morgen: Noch bevor der Markt erwacht, könnte es jetzt explosiv werden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von MassDevice

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiIntuitive wins expanded FDA indications for da Vinci SP for trio of new procedures
MiImpulse Dynamics raises $158M for heart failure treatment
MiMedtronic reports first commercial use of Liberant thrombectomy system
MiNew insurance policy benefits Boston Scientific Intracept procedure
MiNeuralink picks FDA leader to head up medical affairs
MiMirai Medical raises $8.4M to support PFA tech
MiHeartBeam earns FDA clearance for first-ever cable-free 12-lead ECG for at-home arrhythmia assessment
MiCeribell gets FDA nod for delirium monitoring
DiFrancis Medical wins FDA nod for water vapor ablation system
DiMedical Microinstruments wins FDA nod for surgical robot instruments
DiBoston Scientific buys new Minnesota facility for nearly $189M
DiTeleflex completes $2.03B sale of Acute Care, Urology, OEM businesses
DiAlcon amends Staar merger agreement as deal looks set to move forward
DiFormer Verb Surgical CEO to chair BCI maker InBrain Neuroelectronics' board
DiPulse Biosciences to evaluate PFA in treating thyroid cancer
DiSaluda Medical raises $150M in Australian IPO to support neuromod tech
DiLungpacer reports first commercial procedures with AeroPace neurostim system
MoOwens & Minor names new COO as CHRO departs
MoMedtronic has a new head of investor relations, former head to join Diabetes spin-off MiniMed
MoAbbott expands Lingo OTC CGM to Android devices
MoResmed wins FDA clearance for AI-enabled personalized CPAP therapy device
MoSS Innovations submits Mantra surgical robot to FDA for clearance
MoSmith+Nephew outlines new strategy for simpler, higher-growth portfolio
FrFDA panel unanimously votes against Johnson & Johnson MedTech interatrial shunt
FrConmed to exit gastroenterology product lines, transfer Gore Viabil rights to Olympus